IDXG has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IDXG has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.
As of today (2024-05-02), Interpace Biosciences's Volatility is 211.81%.
For the Diagnostics & Research subindustry, Interpace Biosciences's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Interpace Biosciences's Volatility distribution charts can be found below:
* The bar in red indicates where Interpace Biosciences's Volatility falls into.
The annualized volatility is calculated as following:
σA | = | σM | * | √12 |
= | √ 1/(n-1) ∑(Ri - R')^2 | * | √12 |
Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interpace Biosciences (OTCPK:IDXG) Volatility Explanation
Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.
Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.
Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Thank you for viewing the detailed overview of Interpace Biosciences's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.
Christopher Mccarthy | officer: Principal Financial Officer | C/O INTERPACE BIOSCIENCES, INC., 300 INTERPACE PARKWAY; BLDG C, 1ST FLOOR, PARSIPPANY NJ 07054 |
Vijay Aggarwal | director | 2320 SCIENTIFIC PARK DRIVE, WILMINGTON NC 28405 |
Thomas W. Burnell | director, officer: President and CEO | 1355 PEACHTREE STREET, SUITE 1150, ATLANTA GA 30309 |
Peter H Kamin | 10 percent owner | 2720 DONALD ROSS ROAD, #311, PALM BEACH GARDENS FL 33410 |
Fred S. Knechtel | officer: Chief Financial Officer | REMY INTERNATIONAL, INC., 600 CORPORATION DR., PENDLETON IN 46064 |
Fortunato R. Rocca | director | C/O EXAGEN INC., 1261 LIBERTY WAY, SUITE, VISTA CA 92081 |
Edward Chan | director | C/O 1315 CAPITAL II, L.P., 2929 WALNUT STREET, SUITE 1240, PHILADELPHIA PA 19104 |
1315 Capital Ii, L.p. | 10 percent owner | 2929 WALNUT STREET, SUITE 1240, PHILADELPHIA PA 19104 |
Robert J. Gorman | director | C/O INTERPACE DIAGNOSTICS GROUP, INC., 300 INTERPACE PARKWAY, PARSIPPANY NJ 07054 |
Laurence Mccarthy | director | 2110 RUTHERFORD ROAD, CARLSBAD CA 92008 |
Ampersand 2018 Limited Partnership | 10 percent owner | 55 WILLIAM STREET, SUITE 240, WELLESLEY MA 02481 |
Eric B. Lev | director, 10 percent owner | C/O INTERPACE DIAGNOSTICS GROUP, INC., 300 INTERPACE PARKWAY, PARSIPPANY NJ 07054 |
Thomas John Freeburg | officer: Chief Accounting Officer | INTERPACE DIAGNOSTICS GROUP, INC., 300 INTERPACE PKWY, BLDG. C, PARSIPPANY NJ 07054 |
Gregory Richard | officer: Chief Commerical Officer | C/O INTERPACE DIAGNOSTICS GROUP, INC., 300 INTERPACE PARKWAY, BUILDING A, PARSIPPANY NJ 07054 |
Felice Schnoll-sussman | director | C/O INTERPACE DIAGNOSTICS GROUP, INC., 300 INTERPACE PARKWAY, BUILDING A, PARSIPPANY NJ 07054 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 05-11-2022
By GuruFocusNews GuruFocusNews • 01-27-2022
By Marketwired Marketwired • 10-28-2021
By Marketwired Marketwired • 04-22-2021
By GlobeNewswire GlobeNewswire • 01-03-2022
By GlobeNewswire GlobeNewswire • 08-31-2022
By GlobeNewswire GlobeNewswire • 09-01-2022
By GuruFocusNews GuruFocusNews • 06-20-2022
By GuruFocusNews GuruFocusNews • 01-12-2022
By Value_Insider Value_Insider • 10-20-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.